These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35836837)

  • 1. Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction].
    Int J Nanomedicine; 2022; 17():3055-3056. PubMed ID: 35836837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells.
    Hong W; Shi H; Qiao M; Gao X; Yang J; Tian C; Zhang D; Niu S; Liu M
    Int J Nanomedicine; 2017; 12():989-1007. PubMed ID: 28243082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c(RGDyK)-Decorated Pluronic Micelles for Enhanced Doxorubicin and Paclitaxel Delivery to Brain Glioma [Retraction].
    Int J Nanomedicine; 2022; 17():5603-5604. PubMed ID: 36444198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction].
    Int J Nanomedicine; 2022; 17():2319-2320. PubMed ID: 35637839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive, dual-function prodrug encapsulated in hyaluronic acid micelles to overcome doxorubicin resistance.
    Qiu L; Xu J; Ahmed KS; Zhu M; Zhang Y; Long M; Chen W; Fang W; Zhang H; Chen J
    Acta Biomater; 2022 Mar; 140():686-699. PubMed ID: 34875359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green Synthesis of Silver Nanoparticles Using Extract of
    Int J Nanomedicine; 2022; 17():2805-2806. PubMed ID: 35791306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
    Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
    Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro Evaluation of Doxorubicin-Loaded Fe
    Int J Nanomedicine; 2020; 15():5573-5574. PubMed ID: 32848388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
    Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
    Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer.
    Wang H; Li F; Du C; Wang H; Mahato RI; Huang Y
    Mol Pharm; 2014 Aug; 11(8):2600-11. PubMed ID: 24405470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
    Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
    Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro.
    Hwang MH; Li XJ; Kim JE; Jeong SY; Lee SW; Lee J; Ahn BC
    PLoS One; 2015; 10(8):e0136209. PubMed ID: 26295571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Therapeutic Effect of Methotrexate-Conjugated Pluronic-Based Polymeric Micelles on the Folate Receptor-Rich Tumors Treatment [Retraction].
    Int J Nanomedicine; 2022; 17():5601-5602. PubMed ID: 36444197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolated Chitosan Nanoparticles as a Delivery System for Antisense Therapy: Evaluation against EGFR in T47D Breast Cancer Cells [Retraction].
    Int J Nanomedicine; 2022; 17():3581-3582. PubMed ID: 35983481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
    Zhou Y; Wang S; Ying X; Wang Y; Geng P; Deng A; Yu Z
    Int J Nanomedicine; 2017; 12():6153-6168. PubMed ID: 28883726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed Micelles for Targeted and Efficient Doxorubicin Delivery to Multidrug-Resistant Breast Cancer Cells.
    Jung H; Mok H
    Macromol Biosci; 2016 May; 16(5):748-58. PubMed ID: 26806493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
    Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y
    Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PA-MSHA inhibits the growth of doxorubicin-resistant MCF-7/ADR human breast cancer cells by downregulating Nrf2/p62.
    Wei Y; Liu D; Jin X; Gao P; Wang Q; Zhang J; Zhang N
    Cancer Med; 2016 Dec; 5(12):3520-3531. PubMed ID: 27758045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed micelles based on a pH-sensitive prodrug and TPGS for enhancing drug efficacy against multidrug-resistant cancer cells.
    Sun D; Lv X; Wang X; Yu A; Wang Y
    Colloids Surf B Biointerfaces; 2017 Nov; 159():419-426. PubMed ID: 28823972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.